Cargando…
Advances in Understanding the Effects of Erythropoietin on Renal Fibrosis
Renal fibrosis is the common manifestation of the pathogenesis of end-stage renal disease that results from different types of renal insult, and is a hallmark of chronic kidney disease (CKD). The main pathologic characteristics of renal fibrosis are renal interstitial fibroblast hyperplasia and the...
Autores principales: | Zhang, Yangyang, Zhu, Xiaoyu, Huang, Xiu, Wei, Xuejiao, Zhao, Dan, Jiang, Lili, Zhao, Xiaoxia, Du, Yujun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046585/ https://www.ncbi.nlm.nih.gov/pubmed/32154256 http://dx.doi.org/10.3389/fmed.2020.00047 |
Ejemplares similares
-
Metabolic Reprogramming and Renal Fibrosis
por: Zhu, Xiaoyu, et al.
Publicado: (2021) -
Effects of Statins on Lipid Profile of Kidney Transplant Recipients: A Meta-Analysis of Randomized Controlled Trials
por: Huang, Xiu, et al.
Publicado: (2020) -
Molecular mechanisms underlying the role of hypoxia-inducible factor-1 α in metabolic reprogramming in renal fibrosis
por: Wei, Xuejiao, et al.
Publicado: (2022) -
Baseline Soluble Anti-erythropoietin Antibody Level Is an Independent Associated Factor for Follow-Up Erythropoietin Demand in Maintenance Dialysis Patients With End-Stage Renal Disease: A Prospective Cohort Study
por: Zhang, Ying, et al.
Publicado: (2020) -
mTOR Inhibitors Induce Erythropoietin Resistance in Renal Transplant Recipients
por: Jefferies, Reece, et al.
Publicado: (2022)